{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:23:21Z","timestamp":1790357001731,"version":"4.1.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"4","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23-DK103918 (PI: J.E.L.) and K23DK090209 (PI: K.A.F.)"],"award-info":[{"award-number":["K23-DK103918 (PI: J.E.L.) and K23DK090209 (PI: K.A.F.)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,1]]},"DOI":"10.1093\/ckj\/sfx048","type":"journal-article","created":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T23:10:06Z","timestamp":1493421006000},"page":"564-572","source":"Crossref","is-referenced-by-count":26,"title":["Effect of kidney donor hepatitis C virus serostatus on renal transplant recipient and allograft outcomes"],"prefix":"10.1093","volume":"10","author":[{"given":"Jordana B.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Eddinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayme E.","family":"Locke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Forde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre","family":"Sawinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,7,11]]},"reference":[{"key":"key\n\t\t\t\t20171012105557_sfx048-B1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1525-139X.2005.18108.x","article-title":"National surveillance of dialysis-associated diseases in the United States, 2002","volume":"18","year":"2005","journal-title":"Semin Dial"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B2","first-page":"249","article-title":"Epidemiology and clinical significance of hepatotropic infections in dialysis patients. Recent evidence","volume":"56","year":"2004","journal-title":"Minerva Urol Nefrol"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B3","first-page":"CD007003","article-title":"Interventions for dialysis patients with hepatitis C virus (HCV) infection","volume":"8","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/ki.2015.74","article-title":"Superior outcomes in HIV-positive kidney transplant patients compared with HCV-infected or HIV\/HCV-coinfected recipients","volume":"88","year":"2015","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B5","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1600-6143.2010.03091.x","article-title":"Underutilization of hepatitis C positive kidneys for hepatitis C positive recipients","volume":"10","year":"2010","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJMp1505074","article-title":"Transplanting hepatitis C positive kidneys","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B7","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/ajt.13518","article-title":"Efficacy and safety of sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation","volume":"16","year":"2016","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B8","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/ajt.13620","article-title":"Successful treatment of hepatitis C in renal transplant recipients with direct-acting antiviral agents","volume":"16","year":"2016","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B9","doi-asserted-by":"crossref","first-page":"e0158431","DOI":"10.1371\/journal.pone.0158431","article-title":"Efficacy and safety of direct acting antivirals in kidney transplant recipients with chronic hepatitis C virus infection","volume":"11","year":"2016  14","journal-title":"PLoS ONE"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B10","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1111\/j.1600-6143.2010.03280.x","article-title":"Long-term experience with kidney transplantation from hepatitis C positive donors into hepatitis C positive recipients","volume":"10","year":"2010","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B11","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/TP.0000000000000479","article-title":"Shorter waitlist times and improved graft survivals are observed in patients who accept hepatitis C virus+ renal allografts","volume":"99","year":"2015","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B12","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1097\/01.ASN.0000034944.90425.75","article-title":"Donor hepatitis C seropositivity: clinical correlates and effect on early graft and patient survival in adult cadaveric kidney transplantation","volume":"13","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B13","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1046\/j.1600-6143.2004.00606.x","article-title":"The impact of transplantation with deceased donor hepatitis C-positive kidneys on survival in wait-listed long term dialysis patients","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B14","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1016\/j.transproceed.2010.04.056","article-title":"Kidney grafts from HCV-positive donors: advantages and disadvantages","volume":"42","year":"2010","journal-title":"Transplant Proc"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/TP.0b013e3181ac620b","article-title":"A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index","volume":"88","year":"2009","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B16","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/ki.2015.325","article-title":"National outcomes of kidney transplantation from deceased diabetic donors","volume":"89","year":"2016","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B17","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/TP.0b013e3182a688e5","article-title":"Predictors of graft failure and death in elderly kidney transplant recipients","volume":"96","year":"2013","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/ctr.12294","article-title":"Long-term outcomes in African American kidney transplant recipients under contemporary immunosuppression: a 4-year analysis of the Mycophenolic acid Observational REnal transplant (MORE) study","volume":"28","year":"2014","journal-title":"Clin Transplant"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B19","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","year":"2009","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B20","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/pds.969","article-title":"Principles for modeling propensity scores in medical research: a systematic literature review","volume":"13","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1524-4733.2006.00130.x","article-title":"Too much ado about propensity score models? Comparing methods of propensity score matching","volume":"9","year":"2006","journal-title":"Value Health"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1020363010465","article-title":"Using propensity scores to help design observational studies: application to the tobacco litigation","volume":"2","year":"2001","journal-title":"Health Serv Outcomes Res Methodol"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B23","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/sim.5705","article-title":"The performance of different propensity score methods for estimating marginal hazard ratios","volume":"32","year":"2013","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B24","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1080\/01621459.1989.10478874","article-title":"The robust inference for the cox proportional hazards model","volume":"84","year":"1989","journal-title":"J Am Stat Assoc"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B25","volume-title":"Modeling Survival Data: Extending the Cox Model","year":"2001"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B27","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1097\/01.ASN.0000145896.16153.43","article-title":"Acute humoral rejection and renal allograft survival","volume":"15","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B28","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1600-6143.2005.01230.x","article-title":"Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss","volume":"6","year":"2006","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B29","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJM199302183280703","article-title":"Membranoproliferative glomerulonephritis associated with hepatitis C virus infection","volume":"328","year":"1993","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B30","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/ki.2011.194","article-title":"Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy","volume":"80","year":"2011","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1034\/j.1600-6143.2001.10212.x","article-title":"Hepatitis C virus infection and de novo glomerular lesions in renal allografts","volume":"1","year":"2001","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B32","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/00007890-199510150-00004","article-title":"Hepatitis C superinfection in Hepatitis C virus (HCV) infected patients transplanted with an HCV infected kidney","volume":"60","year":"1995","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20171012105557_sfx048-B33","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.cgh.2016.03.040","article-title":"Disparities in absolute denial of modern hepatitis C therapy by type of insurance","volume":"14","year":"2016","journal-title":"Clin Gastroetnerol Hepatol"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/10\/4\/564\/19377125\/sfx048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T10:56:25Z","timestamp":1507805785000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ckj\/article\/10\/4\/564\/3956639\/Effect-of-kidney-donor-hepatitis-C-virus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,11]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,7,11]]},"published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfx048","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,8]]},"published":{"date-parts":[[2017,7,11]]}}}